Wu et al 1 conducted an interesting study-level meta-analysis comparing the efficacy of PD-1 antibody plus chemotherapy with chemotherapy alone in patients with PD-L1–expressing esophageal squamous ...
Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study ...
In a longitudinal clinical study to compare two groups, the primary end point is often the time to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely used to ...
Earn Your Graduate Structural Engineering Certificate in Hazard Analysis from One of the Top Schools for Engineering. Hazard analysis is about helping to prepare vital infrastructure for natural ...
Cigarette smoking and cardiovascular risk increased even with 2 to 5 cigarettes daily, while smoking cessation delivered the ...
The First Phase III Study Testing Ivonescimab Now Represents the First Statistically Significant OS Benefit Achieved by an Ivonescimab-Containing Regimen Ivonescimab Plus Chemotherapy Demonstrates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback